BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 28, 2014
View Archived Issues
Celgene acquires late-stage product for Crohn's disease
Read More
IO-125 supramolecular oxaliplatin analogue shows improved anticancer efficacy
Read More
Fluorinov compounds show activity against pain and epilepsy
Read More
Genentech LDH-A inhibitor targets glycolysis in tumors
Read More
AbbVie presents A-366, an inhibitor of G9a/GLP
Read More
Merck & Co. discloses new MAPK inhibitors for cancer
Read More
Janssen Biotech patents novel anti-TLR3 antibodies
Read More
Japanese researchers prepare new nACh receptor agonists for pruritus
Read More
Vernalis reports data from a phase Ib/II study of V-81444
Read More
Hyperion Therapeutics to acquire Andromeda Biotech
Read More
Amgen reviews milestone progress of first quarter 2014
Read More
PAR-1 antagonist F-16357 dose-dependently inhibits bladder contraction
Read More
MiR-296 presented as a prognostic and predictive molecular biomarker for laryngeal carcinoma
Read More
Chugai Pharmaceutical updates progress of first quarter 2014
Read More
Teva and Takeda sign agreement for rasagiline in Japan
Read More
Daiichi Sankyo licenses Agendia biomarker technology for cancer drug development
Read More
EMA approves canagliflozin and metformin combination
Read More
Boehringer Ingelheim's antithrombotic receives positive opinion from the EMA
Read More
FDA grants fast track designation to Sativex
Read More
EMA committee recommends approval of Mekinist
Read More
TB Alliance advancing PaMZ drug regimen for TB into phase III testing
Read More
Investigator-sponsored trial to study bavituximab and ipilimumab in advanced melanoma
Read More
Merck KGaA patent describes novel PARP/TANK inhibitors
Read More
FDA notes deficiencies at active ingredient supplier for Pozen's PA-8140, PA-32540
Read More